Drug Topics

JULY 2, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

Vaccines 520

Vaccines Immunization Compounding Communication 520

IDStewardship

JANUARY 8, 2025

In this article, five key skills for pharmacy residents are identified and discussed. Authored by:Asma Alamri, Pharm.D. &Huda Almalki, Pharm.D. Post-Graduate Year-1Pharmacy Residents, Taif Health Cluster, Saudi Arabia Mentored by: Sameer Alzaidi, Pharm.D., BCPS, BCIDP, AAHIVP System-Wide Post-Graduate Year-1Pharmacy Residency Program Director, Taif Health Cluster, Saudi Arabia UNDER CONSTRUCTION Article Posted January 2024 According to the American College of Clinical Pharmacy (ACCP a reside

Health and Personal Care Stores 334

Health and Personal Care Stores Patient Care Hospitals 334

Pharmacy Times

JULY 17, 2025

The FDA approves a prefilled syringe for the zoster vaccine recombinant, enhancing shingles vaccination convenience and effectiveness for adults 50 and older.

Vaccines 111

Vaccines FDA 111

Hospital Pharmacy Europe

JULY 3, 2025

The NHS 10-year plan will see pharmacists among the staff leading the Government’s new neighbourhood health centres, the Prime Minister has announced. This will reduce pressure and demand on hospitals and allow secondary care teams to focus on specialist care supported by technology to improve productivity. Sir Keir Starmer set out the details of the highly anticipated 10-year plan for the NHS – largely focusing on the Government’s ambitions for a Neighbourhood Health Service.

Community Pharmacies 52

Community Pharmacies Hospitals Communication 52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

European Pharmaceutical Review

JUNE 26, 2025

EPR Issue 2 includes articles on the impact of tariffs on the pharmaceutical supply chain, advances in bioprocessing, the potential of digital twins in manufacturing, cell and gene therapies and more. Included in this issue of European Pharmaceutical Review : FOREWORD Setting rationale specifications for early-phase non-mutagenic impurities David Elder David P Elder Consultancy SUPPLY CHAIN Tariff risks and opportunities for pharma manufacturers Clifford Rossi, PhD, University of Maryland IN-D

52

52

PharmaVoice

JULY 10, 2025

ICER’s upcoming report could shed light on how the launch price of newly approved drugs affects overall cost and access from a patient perspective.

226

226

Pharma Marketing Network

JUNE 21, 2025

In 2025, the landscape of healthcare marketing is evolving faster than ever—and nowhere is this more evident than on social media. As patients, providers, and pharmaceutical brands increasingly interact online, “Social Media Strategies” have become mission-critical for staying relevant and compliant. But how can pharma marketers leverage these channels effectively in the second half of the year?

Prescription Filling 52

Prescription Filling FDA 52

DiversifyRx

JUNE 19, 2025

Running an independent pharmacy means balancing inventory, staff, compliance, and patient care—all at once. Pharmacy automation offers a powerful solution: save time, boost accuracy, enhance efficiency, and elevate patient care—without having to hire a bunch of staff. Technology can truly transform your pharmacy. Here’s how to integrate pharmacy automation into your operations.

Independent Pharmacies 52

Independent Pharmacies Patient Care Communication Packaging 52

The Checkup by Singlecare

JUNE 16, 2025

The U.S. Food and Drug Administration (FDA) has approved Widaplik, a new triple combination medication designed to treat high blood pressure in adults. Widaplik is the first single pill containing three different drugs approved as an initial treatment for hypertension. It’s a huge win for people who would otherwise likely need several different prescriptions to optimize their cardiovascular health.

FDA 66

FDA Packaging Dosage 66

The FDA Law Blog

JULY 8, 2025

By Charles D. Snow — Recently, FDA announced a deadline shift, although the Agency did so quietly. On June 23, 2025, FDA updated its CDER Nitrosamine Impurity Acceptable Intake Limits webpage to permit manufacturers and sponsors more time to submit required changes for nitrosamine drug substance‑related impurities (NDSRIs) for approved or currently marketed products.

FDA 59

FDA Documentation Communication 59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

JUNE 12, 2025

SF 383 prohibits PBMs from limiting patient choice of pharmacy, unfairly excluding pharmacies from networks, and forces them to reimburse pharmacies no less than what they pay affiliated pharmacies for the same drug.

545

545

IDStewardship

JUNE 19, 2025

AI-Generated Summary This article by infectious diseases pharmacist Aneeka Chavda outlines five key considerations for pharmacists in the treatment of Mycobacterium tuberculosis (TB), particularly drug-sensitive cases. It emphasizes the critical but potentially underdosed role of rifampicin, highlighting research into higher doses that may improve outcomes.

HIV Treatment and Prevention Agents 130

HIV Treatment and Prevention Agents Adverse Reactions Dosage Labelling 130

Pharmacy Times

JULY 17, 2025

An expert discusses how pharmacists can ensure completion of multidose pneumococcal vaccine series through electronic reminder systems, state immunization registries, scheduled follow-up appointments, and providing patients with printed vaccine cards for tracking purposes.

Vaccines 65

Vaccines Immunization 65

Hospital Pharmacy Europe

JULY 1, 2025

With the impact of digital technologies on healthcare provision and the workforce ramping up, Matthew Spence, clinical digital lead for medicines management and pharmacy services at Leeds Teaching Hospitals NHS Trust, offers practical tips and strategies based on insights and initiatives from his own hospital to support pharmacy teams in navigating digital transformation.

Hospitals 84

Hospitals Documentation Communication 84

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

European Pharmaceutical Review

JUNE 19, 2025

The European Medicines Agency (EMA) has published a draft reflection paper that signals a potential evolution in the regulatory landscape for biosimilar development within the EU. 1 Rather than representing a radical break from established practice, the document builds on decades of scientific and regulatory experience, proposing that – under certain well-defined conditions – the demonstration of bio-similarity might rely more heavily on advanced analytical characterisation and pharmacokinetic (

Packaging 97

Packaging Documentation 97

PharmaVoice

JUNE 23, 2025

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

Packaging 147

Packaging 147

Pharmaceutical Commerce

JUNE 18, 2025

News News Pharma Pulse Academy Publications Partner Perspectives Webcasts Resources Conferences Conference Coverage Conference Listing Events Videos Videos Peer Exchange Podcasts Editorial Podcasts Sponsored Podcasts Subscribe Choose Specialty Brand & Product Security Brand & Product Security Brand & Product Security Brand & Product Security Business and Finance Cold Chain Cold Chain Cold Chain Cold Chain Commercial Channels Data & Technology Data & Technology Data &

Specialty Pharmacies 52

Specialty Pharmacies Documentation FDA 52

Pharma Marketing Network

JUNE 16, 2025

In an industry defined by compliance, complexity, and fierce competition, connecting with healthcare professionals (HCPs) effectively is both an art and a science. That’s where HCP targeting comes in—an evolving pillar of pharmaceutical marketing that blends precision, personalization, and performance. Pharma brands know that not all doctors are equal when it comes to prescribing behavior, influence, or engagement preferences.

HIPAA 52

HIPAA Communication Patient Care FDA 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmafile

JULY 8, 2025

Theramex, a women’s health pharma company, has announced that the Scottish Medicines Consortium has recommended Eladynos (abaloparatide) for NHS use in Scotland. This offers a new treatment option for postmenopausal women at high risk of fracture. Osteoporosis is a progressive condition causing fragile bones and fractures. Hip fractures alone are responsible for around 50% of […] The post SMC recommends Eladynos for postmenopausal osteoporosis in Scotland appeared first on Pharmafile.

59

59

Med Ed 101

JUNE 29, 2025

Fluconazole is a commonly used antifungal agent with strong CYP450 inhibitory activity, especially on the CYP2C9, CYP2C19, and CYP3A4 enzymes. Because of this, it can significantly affect the metabolism of many medications. Here are my top five fluconazole drug interactions that pharmacists should be aware of. Warfarin One of the most clinically significant interactions is […] The post Top 5 Fluconazole Drug Interactions appeared first on Med Ed 101.

52

52

The FDA Law Blog

JUNE 30, 2025

By Larry K. Houck — A memorable Florida Orange Growers’ television ad campaign in the late 1970s proclaimed that “Orange juice from Florida isn’t just for breakfast anymore.” The Federal Controlled Substances Act (“CSA”) and its regulations require Drug Enforcement Administration (“DEA”) registrants to submit certain reports related to narcotic drug transactions, thefts and significant losses, and suspicious orders.

Controlled Substances 59

Controlled Substances Hospitals 59

Drug Topics

JULY 14, 2025

Panelists discuss how pharmacists should educate patients about pneumococcal vaccines by providing current vaccine information statements (VIS) updated May 29, 2025, explaining common adverse effects like injection site reactions and mild systemic symptoms as normal immune responses, conducting thorough pre-vaccination screening for moderate-to-severe illness, allergies to vaccine components (noting that conjugated vaccines contain yeast), and history of fainting or anxiety, while emphasizing th

Vaccines 247

Vaccines Communication Immunization 247

Pharmaceutical Technology

JUNE 26, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Compounding 86

Compounding Communication Packaging Labelling 86

Pharmacy Times

JULY 16, 2025

New research highlights the benefits of early oseltamivir treatment for hospitalized patients with influenza, reducing mortality and readmission rates while optimizing care.

Hospitals 81

Hospitals 81

Hospital Pharmacy Europe

JUNE 26, 2025

As president of the International Society of Oncology Pharmacy Practitioners and co-chair of the UK SACT Board, Netty Cracknell is championing the role of oncology pharmacy in delivering high-quality cancer care worldwide and supporting progress, as Saša Janković explains. Halfway through her two-year tenure as president of the International Society of Oncology Pharmacy Practitioners (ISOPP), not to mention her role as co-chair of The UK Systemic Anti-Cancer Therapy (SACT) Board, Netty Cracknell

Patient Care 52

Patient Care Hospitals Documentation 52

European Pharmaceutical Review

JULY 15, 2025

New research reveals that while 52 percent of pharmaceutical companies remain in early stages of digitalisation, leading manufacturers are finding innovative ways to overcome data fragmentation and drive operational efficiency. The pharmaceutical manufacturing sector stands at a digital crossroads. Despite significant investment in modern technologies, more than half of companies are still struggling with the fundamentals of digitalisation, according to recent research conducted by Hexagon in pa

Documentation 59

Documentation Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

JULY 17, 2025

EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.

66

66

Fierce Pharma

JULY 9, 2025

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA approves a new dosing regimen of the drug with an improved safety profile.

FDA 89

FDA 89

Pharma Marketing Network

JUNE 19, 2025

The intersection of artificial intelligence and pharmaceutical marketing is creating new waves of innovation. In 2025, AI generated marketing campaigns are no longer experimental. They are being deployed to personalize content, predict engagement, and automate outreach. But is the pharma industry truly ready to embrace these capabilities? Table of Contents What Are AI Generated Marketing Campaigns?

HIPAA 64

HIPAA FDA 64

The Checkup by Singlecare

JULY 15, 2025

Bupropion is a prescription medication that affects chemicals in the brain linked to mood and cravings. It’s used to treat a range of conditions, including depression, seasonal mood changes, and even to support smoking cessation. Not all forms of bupropion are the same, and the dosage and purpose can vary depending on the specific product. For example, Wellbutrin XL (bupropion) is a common bupropion product that’s approved by the Food and Drug Administration (FDA) to treat major depressive disor

Dosage 52

Dosage FDA 52

Med Ed 101

JUNE 22, 2025

Nonsteroidal anti-inflammatory drugs (NSAIDs) are routinely used for pain and inflammation, but they are also commonly implicated in clinically significant interactions. As medication experts, pharmacists play a critical role in recognizing and navigating these risks. Below are five of the most important NSAID drug interactions that pharmacists should watch for in daily practice.

52

52

PharmTech

JULY 4, 2025

Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.

45

45

Drug Topics

JULY 7, 2025

Panelists discuss how pharmacists should ensure patients receive at least one conjugated pneumococcal vaccine (PCV-15, PCV-20, or PCV-21) as the foundation of protection, with subsequent vaccine sequencing depending on which initial vaccine was given—where PCV-15 recipients should receive PPSV-23 one year later for additional serotype coverage, patients with prior PCV-13 need PCV-20 or PCV-21 after a one-year interval, and immunocompromised patients or those with cochlear implants/CSF leaks can

Vaccines 247

Vaccines 247